CHRS – coherus biosciences, inc. (US:NASDAQ)
Stock Stats
News
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
Coherus BioSciences (CHRS) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Form SC 13G Coherus BioSciences, Filed by: Rubric Capital Management LP
Form 10-Q Coherus BioSciences, For: Sep 30
Form 8-K Coherus BioSciences, For: Nov 06
Form 8-K Coherus BioSciences, For: Sep 13
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.